Cardinal Health, Inc. Common St (NYSE:CAH):
Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2017 on Oct. 31.
The company is unchanged by 0.00% since yesterday’s close of $78.14.
Additionally the company recently declared a dividend for shareholders that will be paid on Saturday the 15th of October 2016. The dividend will be $0.450 per share for the quarter or $1.80 on an annualized basis. This dividend amount will represent a yeild of $2.31. The ex-dividend date will be on Wednesday the 29th of June 2016.
Shares are trading at $78.14 barely below $79.94, the stock’s 50 day moving average and which is just a bit below the 200 day moving average of $80.42. The 50 day moving average went down by -2.25% whereas the 200 day average was down by -2.84%.
The company’s P/E ratio is 18.09 and market cap is 24.89B. In the latest earnings report the EPS was $4.32 and is expected to be $5.60 for the current year with 318,588,000 shares outstanding. Next quarter’s EPS is estimated at $1.41 with next year’s EPS anticipated to be $6.24.
Several investment analysts have weighed in on the company of late. On September 16 the stock rating was downgraded to “Neutral” from “Conviction Buy” and a price target of $83.00 was set in an announcement from Goldman Sachs. Equity analyst Avondale Partners started covering CAH with an initial rating of “Market Outperform” and setting a price target of $111.00.
On March 15 the company was downgraded from “Outperform” to “Market Perform” with a current price target of $90.00 in a report from Cowen & Company. On March 15 analysts at Credit Suisse began coverage of the stock setting a rating of “Outperform” and price target of $102.00.
Cowen & Company downgraded the stock and lowered the price target on March 15 cutting the price target from $99.00 to $90.00 and moving the rating from “Outperform” to “Market Perform”. On March 7 the stock rating was upgraded from “Buy” to “Conviction Buy” in a statement from Goldman Sachs.